Filing Details

Accession Number:
0001225208-18-001052
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-16 17:12:57
Reporting Period:
2018-01-12
Accepted Time:
2018-01-16 17:12:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168014 M Mirian Weir Graddick Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth NJ 07033
Exe V-P, Hr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-12 5,000 $58.00 101,484 No 4 S Direct
Common Stock Acquisiton 2018-01-16 52,000 $44.30 153,484 No 4 M Direct
Common Stock Disposition 2018-01-16 8,000 $61.63 145,484 No 4 S Direct
Common Stock Disposition 2018-01-16 52,000 $61.63 93,484 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-01-16 52,000 $0.00 52,000 $44.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-02-28 2018-02-28 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
  2. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
  3. Holdings include shares acquired in dividend reinvestment transactions.
  4. The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.